Want to join the conversation?
Omar Saad with Evercore asks about Misfit and what's happening with that business. $FOSL said the company's investment thesis and its goals for the Misfit acquisition are playing out pretty much exactly as it had hoped. The company has beat its internal integration goals and is on track on its product delivery expectations.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?